Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson consumer Health segment income before tax ($M) [through FY2023Q2] ($M)
Form 10-Q / 10-K Segment Note
Latest, FY2022
2,930
Period ended Jan 1, 2023
Change on a year earlier
+86.3%
1,573 in FY2021
History
8 years
Since FY2015
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consumer Health segment income before tax ($M) [through FY2023Q2] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Jan 1, 2023 | 2,930 | +86.3% | Form 10-K (filed 2023-02-16) ↗ |
| FY2021 | Jan 2, 2022 | 1,573 | -284.6% | Form 10-K (filed 2023-02-16) ↗ |
| FY2020 | Jan 3, 2021 | -852 | -141.3% | Form 10-K (filed 2023-02-16) ↗ |
| FY2019 | Dec 29, 2019 | 2,061 | -11.2% | Form 10-K (filed 2022-02-17) ↗ |
| FY2018 | Dec 30, 2018 | 2,320 | -8.1% | Form 10-K (filed 2021-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 2,524 | +3.4% | Form 10-K (filed 2019-02-20) ↗ |
| FY2016 | Jan 1, 2017 | 2,441 | +36.6% | Form 10-K (filed 2019-02-20) ↗ |
| FY2015 | Jan 3, 2016 | 1,787 | – | Form 10-K (filed 2018-02-21) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Consumer Health segment income before tax ($M) [through FY2023Q2] ($M), annual FY2015–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/seg_pti_ch_legacy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.